We are live on ! Find out more

1,603 hedge funds and large institutions have $124B invested in Merck in 2014 Q1 according to their latest regulatory filings, with 116 funds opening new positions, 596 increasing their positions, 703 reducing their positions, and 64 closing their positions.

New
Increased
Maintained
Reduced
Closed

81% more first-time investments, than exits

New positions opened: 116 | Existing positions closed: 64

38% more call options, than puts

Call options by funds: $1.01B | Put options by funds: $733M

30% more funds holding in top 10

Funds holding in top 10: 113147 (+34)

14% more capital invested

Capital invested by funds: $109B → $124B (+$15.3B)

2% more funds holding

Funds holding: 1,5671,603 (+36)

0.06% less ownership

Funds ownership: 74.45%74.39% (-0.06%)

15% less repeat investments, than reductions

Existing positions increased: 596 | Existing positions reduced: 703

Holders
1,603
Holders Change
+36
Holders Change %
+2.3%
% of All Funds
46.13%
Holding in Top 10
147
Holding in Top 10 Change
+34
Holding in Top 10 Change %
+30.09%
% of All Funds
4.23%
New
116
Increased
596
Reduced
703
Closed
64
Calls
$1.01B
Puts
$733M
Net Calls
+$278M
Net Calls Change
-$156M

MRK Hedge Fund Activity: Q1 2014 in Review

1,603 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q1 2014, worth a combined $124B — up 14% from $109B a quarter earlier.

Buyers outnumbered sellers: 116 funds opened new MRK positions and 64 closed out — a net gain of 52 holders — while 596 added to existing stakes and 703 trimmed.

The largest buyer was Jennison Associates, adding an estimated $608M. The largest seller was Dodge & Cox, cutting an estimated $480M.

  • 1,603 institutional investors held Merck (MRK) as of Q1 2014, up from 1,567 in Q4 2013.
  • Funds reported $124B of Merck stock for Q1 2014, up 14% quarter-over-quarter.
  • 116 funds opened new Merck positions in Q1 2014 and 64 closed out, a net change of +52 holders.
  • The largest Merck buyer in Q1 2014 was Jennison Associates, an estimated $608M added.
  • The largest Merck seller in Q1 2014 was Dodge & Cox, an estimated $480M sold.

Based on aggregated 13F filings for Q1 2014.